News
Wegovy, Novo Nordisk and fatty liver disease
Digest more
Wegovy is now approved by the FDA to treat metabolic-associated steatohepatitis in adults with moderate-to-advanced fibrosis ...
While the 10-fold increase in dose over injectable Wegovy has raised questions about the launch, Novo Nordisk has assured ...
GoodRx will offer the GLP-1s for $499 a month, the lowest-ever out-of-pocket cost for the weight-loss medications.
In a significant development for weight management, the Food and Drug Administration (FDA) announced Wednesday its approval ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results